Press Releases
Graves disease Market Analysis and Research Report by Experts 2017 - 2025

, 16 April 2019 -- Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S.

In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism. Graves’ disease is the most predominant cause of hyperthyroidism in the U.S. A study conducted in Minnesota estimated the incidence of the disease at 30 cases per 1 million persons. Approximately 1 in every 500 women has maternal thyrotoxicosis. According to the Wickham study in England, Graves’ disease accounted for 0.5 cases per 1000 persons, with higher rate of incidence in people aged between 40 and 60. After Hashimoto thyroiditis, Graves’ disease is the most prevalent autoimmune thyroid disorder in the U.S. Through a study conducted by PREGO (presentation of Graves orbitopathy), the annual incidence of Graves’ orbitopathy in Europe was 10-30/10,000 human subjects but over a period of time, the severity and incidence of Graves’ disease in Europe has been observed to decrease to 2.10/10,000/year.

Read Report Overview:

As with most autoimmune diseases, Graves’ disease is also more likely to affect women than men. Hyperthyroidism due to Graves’ disease has a female-to-male ratio of 7-8:1. Typically, it is a disease of young women, but it can occur in persons of any age. The prevalence rate for Graves’ disease is similar in both Asians and Caucasians, but is lower in the African population.

Treatment of Graves’ disease involves reduction of abnormal thyroid hormone levels and relieving the associated discomfort. The three standard treatment options are the use of anti-thyroid drugs, radioactive iodine ablation, and thyroidectomy. All three treatments inhibit overproduction of thyroid hormone. The least invasive and typical first-line therapy for Graves’ disease is the use of anti-thyroid drugs, which slows down thyroid activity and inhibits production of thyroid hormone. Propylthiouracil (PTU) and methimazole (MMI) are inexpensive, devoid of side effects, and are the most commonly used treatment option for this disease.

Iodine-131 is used in radioactive iodine ablation (RIA) to destroy entire or part of the thyroid gland, resulting in prevention of overproduction of thyroid hormone. Removal of the thyroid gland through surgery called subtotal thyroidectomy is one of the most invasive treatment options. Irrespective of the treatment method, patients have to follow long term treatment regimens to ward off the chances of hyperthyroidism or occurrence of hypothyroidism. Thyroid hormone replacement therapy along the length of the patient’s life is necessary. This presents large opportunities for new players in the market.

Rise in number of patients with thyroid disorders, favorable reimbursement policies for treatment, and increase in awareness about the complications associated with thyroid disorders are the major drivers of the Graves’ disease market. Increasing iodine disorder and thyroid tumors screening is one of the leading factors fueling the growth of the market.

Based on the product type Graves’ disease drugs could be classified into Anti-thyroid drugs, Iodine & Iodides, Radioactive Iodine, Ionic Inhibitors. Anti-thyroid drug is further segmented into Beta-adrenergic blockers, thiomides and corticosteroids

The Graves’ disease market is anticipated to witness moderate growth. In terms of region, the Graves’ disease drug market has been segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is anticipated to be the major market for thyroid related disorders followed by Europe. Asia Pacific is likely to be the fastest growing market for thyroid related disorders drugs due to increased health care investments, rise in awareness about hyperthyroidism, and various treatment options available.

Request Brochure of the Report:

Key players in the Graves’ disease market are Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer, Inc., RLC LABS, AbbVie, Inc., Mylan N.V., and Allergan, plc., and others.

About us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

# # #

Submitted by hawer on Tuesday, 16 April 2019 at 2:50 AM
Category: Health Care & Medical
Related News

ePharmacy Market will Likely to Expand at a Steady CAGR of 17.70% from 2015 to 2023
Wednesday, 19 Jun 2019

Cervical Cancer Diagnostic Tests Market is Projected to be Worth US$ 8.9 Bn by 2020
Wednesday, 19 Jun 2019

Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market to Expand at a Modest CAGR of 23.7% from
Wednesday, 19 Jun 2019

Preventive Healthcare Technologies and Services Market is Expected To Demonstrate a CAGR of 9.70% fr
Wednesday, 19 Jun 2019

Points to consider when buying gym wear
Wednesday, 19 Jun 2019

Related Events

2nd Journal of Thermal Analysis and Calorimetry Conference
Tuesday, 18 Jun 2019

Vestibular Schwannoma Conference 2019
Wednesday, 19 Jun 2019

Biomarkers And Diagnostics for Complex And Rare Diseases
Wednesday, 19 Jun 2019

2nd International Public Mental Health Conference
Wednesday, 19 Jun 2019

III World Congress and VI International Congress on Dual Disorders ICDD2019
Wednesday, 19 Jun 2019

Latest News

Global Connected Retail Solutions Market Research Report 2018-2023
Wednesday, 19 Jun 2019

Nu Menu Provides the Perfect Solution for Hospitality Management
Wednesday, 19 Jun 2019

Zoltan David Is One Of The Best Fine Jewelry Designers In Austin At Affordable Prices
Wednesday, 19 Jun 2019

UAE Diesel Genset Market (2019-2025)
Wednesday, 19 Jun 2019

WIMI Hologram AR Cloud Display Exhibits Stunning Effects and High AI Algorithm Simulation
Wednesday, 19 Jun 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 19 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • ESPNIC 2019
  • Palo Alto Networks: Security Simplified - Enterprise Security Series
  • 2nd Journal of Thermal Analysis and Calorimetry Conference
  • EPHJ-EPMT-SMT Trade Show
  • Palo Alto Networks: May - Palo Alto Networks Heads-up

  • Latest Jobs
    Sorry, there are currently no entries posted here.